Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy

(2014) Seraina von Moos et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines

(2013) Sandra Scheiblhofer et al.   Expert Opinion on Drug Delivery

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

(2013) Menno A. Kiel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy

(2012) S. Moos et al.   ALLERGY

Antigen presentation by Langerhans cells

(2012) Botond Z Igyártó et al.   CURRENT OPINION IN IMMUNOLOGY

100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT)

(2011) J. Ring et al.   ALLERGY

Recombinant allergens: What does the future hold?

(2011) Rudolf Valenta et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies

(2011) Louisa K. James et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

(2011) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Advances in transcutaneous vaccine delivery: Do all ways lead to Rome?

(2010) Suzanne M. Bal et al.   JOURNAL OF CONTROLLED RELEASE

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy

(2009) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY